Fighting a Smarter War Against Cancer: Empowering Patients Through Clinical Trials, Symposium 2012

 

Day 1: Friday Session  |  Day 2: Saturday Session


Day 1: Friday, November 30, 2012

Accelerating the Cure through Clinical Research


Introduction to Symposium

John L. Marshall, MD
Director, Ruesch Center for the Cure of Gastrointestinal Cancers
Chief, Division of Hematology/Oncology, Georgetown Lombardi Comprehensive Cancer Center


The State of Cancer Clinical Research in the US and the World: Progress at the 3% Accrual Rate

Moderator: Margo Michaels
Executive Director and President, Education Network to Advance Cancer Clinical Trials


The Role of Government in Clinical Research: Restructuring the NCI's Clinical Trials Program

James Zwiebel, MD
Chief, Investigational Drug Branch, Cancer Therapy Evaluation Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute


The Projected Impact of a 20% Accrual Rate on the Cost of Drug Development

Todd Shuster, MD
Senior Director, Clinical Development, and Oncology Therapeutic Area Co-Leader, PAREXEL International


Accrual in the Community, and the Impact of Sudden Success

Lori Minasian, MD, FACP
Deputy Director, Division of Cancer Prevention, National Cancer Institute


Question & Answer Session

 


Going from 3% to 20%+: The Potential Impact on the Race - Second Introduction

John L. Marshall, MD
Director, Ruesch Center for the Cure of Gastrointestinal Cancers
Chief, Division of Hematology/Oncology, Georgetown Lombardi Comprehensive Cancer Center


Schafer Memorial Lecture

Deborah Schrag, MD, MPH
Associate Professor, Department of Medicine, Harvard Medical School, Adult Oncology, Dana-Farber Cancer Institute


Panel Discussion

Moderator: Brian Rye
Health Care Financial Analyst for Bloomberg Government

Panelists:
Alan Wertheimer, PhD
Senior Research Scholar, Department of Bioethics, National Institutes of Health

Carol Palackdharry, MD, MS
Medical Director, ActiveHealth Management; Clinical Lead, Oncology Condition Analysis, Aetna

Louis Jacques, MD
Director, Coverage & Analysis Group, Office of Clinical Standards and Quality, Centers for Medicare and Medicaid Services


Engaging the Other 97%: Why Aren't Cancer Patients Up in Arms?

Moderator: Amanda Bennett
Author, "The Cost of Hope: A Memoir"
Executive Editor, Bloomberg News


View videos from Day 2 of the Symposium.